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Bone Mineralisation
Pinki Dey
Abstract
The mineralisation term mentions the development of inorganic precipitation 
over an organic background. This process occurs in a life span of biological organ-
ism for the formation of bone, teeth, exoskeletons, egg shells, etc. So, basically 
bone mineralisation is defined as the process of deposition of minerals on the bone 
matrix for the development of bone. The human bone is made up of 60–70% miner-
als which include calcium phosphate in the form of hydroxyapatite followed by 
20–40% organic matrix containing type I collagen fibres and less than 5% of water 
and lipids. During bone mineralisation process osteoblasts which are also known as 
bone forming cells, aids to the production of calcium phosphate crystals which are 
then aligned in the collagen based fibrous matrix. The bone mineralisation proce-
dure also known as calcification is a lifelong activity of a human being.
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1. Introduction
Bone is a multifaceted system which behaves as mechanical shield for providing 
support and security. Bone also plays an important role in haemostasis. Recently, 
it came to observation that bone also aids in functioning of endocrine glands. To 
fulfil all these purposes, bone is a well architecture behaving as a functionally 
graded structure from millimetre to nanometre range. As a result of this gradation 
bone shows an unusual amalgamation of high stiffness and toughness which are 
frequently inversely associated. Broadly, bone is made up of organic and mineral 
part where the organic part is comprised of type I collagen whereas the mineral 
part contains the calcium deficient hydroxyapatite. The mineral part of the bone 
is interlinked with collagen in such an organised manner that it not only provides 
flexibility and ductility to the structure but also shows stiffness. This organisation 
of bone when observed at nanoscale range it behaves as a composite which acts as a 
shield to the brittle hydroxyapatite from damaging and also helps in carrying load 
by transferring forces around the bond hence thereby reducing the stress formation 
in the composite matrix. The fibres of the collagen intermingled with mineral part 
are arranged in very different manner when observed on microscopic range. This 
arrangement at micrometre level completely depends on the rate of bone formation 
or bone location on the substrate. This is due to the various functions played by the 
bone tissue, i.e., during fracture rapid bone formation development of bone during 
growth, unhurried bone formation in order to adjust in accordance to mechanical 
requirements so as to avoid any damage to its structure as well as maintaining its 
mechanical assets. Bone can be divided into two major categories depending on its 
mechanical and biological aspects i.e. cortical bone (compact/dense) and cancellous 
(porous/spongy bone namely trabecular) [1].
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2. Bone composition
The mineral portion of the bone which basically comprises of hydroxyapatite 
contributes to the 65% of weight of bone. The remaining 20–30% of the bone 
weight composed of collagen of Type I. And, the last 10% of weight includes water 
molecules which are present collagen-mineral structure. Also, there are some free 
water molecules in the bone composite which gets redistributed during load bearing 
phase of bone. These free molecules pass through the vascular channels of bones 
and hence play a pivotal role in detection of signals by cells thus transferring infor-
mation regarding load bearing environment. The interaction between bone mineral 
and unbound water molecules in a ratio of 1:1 helps in the process of bone miner-
alisation i.e. when the amount of water declines the mineralisation of bone starts to 
proceed and vice versa. The bone mineralisation is directly related to the stiffness 
of the bone as bone tends to grow stiffer since it contains higher amounts of mineral 
and lesser quantity of water. And as a result of this stiffened bone becomes more 
prone to brittleness and hence fracture easily. Approximately, 90% of organic part 
of bone is made up of collagen of type I category also collagen of type III and V 
are present in very minor quantities. And, the last 10% belong to non-collagenous 
proteins which help in the regulation of collagen development and management of 
fibre size, resistance to micro-crack, cellular adhesion and mineralisation. Around 
85% of non-collagenous proteins are present in extracellular matrix and rest resides 
with the bone cells.
2.1 Collagen
The fibres of collagen are intertwined with the plate like structure of bone. Each 
and every collagen molecule exists as a triple helical structure formed from two 
chains of α 1 and one chain of α 2. Individual chain has around 1000 amino acids 
lengthwise and the centre part of the helix contains triplets of gly-X-Y in repeat-
ing sequence. The glycine molecules help in the formation of helical structure of 
collagen. Basically, all the amino acids are incorporated in collagen but the X and Y 
units are often composed of residue of hydroproline and proline. The maintenance 
of helical rigidity of the chain is due to the proline and hydroproline residues. 
The hydroxyl part of the hydroproline amino acid is important for interaction 
with water molecules via hydrogen bonding. The triple helix structure of collagen 
retained by the water molecules is affined toward hydroxyproline. At intercellular 
stage, peptides of non-helical region, i.e., N-propeptide as well as C-propeptides 
hold the chains at one place by cross- linking with sulphur. The propeptides pres-
ent at the terminal point of triple helix are called procollagen molecule. During 
the exocytosis of molecules, the propeptide parts are broken down enzymatically 
resulting in non-helical parts at the molecular end N or C-terminal respectively. 
The enzymatically cleaved peptides result in the development of mature collagen 
molecule which has a pattern of non-helical N- and C-terminal peptides and helical 
nature of triple helix region. The microfibrils of collagen are semi-hexagonal system 
of five collagen molecules. The lateral and longitudinal combination of microfibrils 
leads to the formation of fibres approximately 10 μm in length and around 150 nm 
in diameter. The collagen fibres when observed under electron microscope showed 
a band pattern of around 67 nm. This band pattern is known as D-banding and it 
demonstrates the area between the neighbouring ends of collagen molecules as well 
as the overlapping between the lateral neighbouring molecules present at the end 
sections. In an osteoporotic bone the average diameter between the collagen fibrils 
and their spacing is very less as compared to a normal bone. The collagen fibrils 
are joined with the help of various types of cross-links which may have influential 
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effects on the materialistic properties of the surrounding tissues and thereby affect-
ing the mechanical traits of the whole bone system. The crosslinks bonds which 
connects the collagen fibrils are broadly categorised into enzymatic crosslinks and 
non-enzymatic crosslinks which forms a AGEs (advanced glycation end products).
2.2 Non collagenous proteins
There are various proteins of non-collagenous nature that helps in the regula-
tion of formation and preservation of the extracellular matrix. Even though they 
comprise only of 2% of bone in weight but NCPs do a very important job during 
embryogenesis and formation as well as establishment of fibrils of collagen. It 
also regulates mineral of formation of bone and deliver channels for all signalling 
regarding the attachment of cells. The NCPs are divided into
1. Proteoglycans: They are basically consisting of various heparin sulphate, hyal-
uronan, small leucine rich proteoglycans called SLRPs. These are wide range of 
molecules where the main proteins are covalently bonded to the lateral chains 
of sulphated glycosaminoglycan. The proteoglycans which are present in the 
bone are smaller in size as compared to the other non-bone region proteogly-
cans. It manages the nucleation of apatite and the growth of apatite which in 
turn controls mineralisation.
2. Glycoproteins: It consists of fibronectin, thrombospondin (TSP1 and TSP2), 
vitronectin and lastly, alkaline phosphatase (ALP). In bones there are huge 
numbers of glycoproteins, out of which functions of few glycoproteins are not 
known. The activity of ALP helps in determining mineralisation factors be-
cause it undergoes hydrolysis with pyrophosphates which, as a result restricts 
the deposition of minerals by tagging itself with mineral crystals. If the pyro-
phosphates are neutralised, then this leads to normal growth of mineral crys-
tals and as a result regulates the bone mineralisation. Since ALP is solely not 
produced by bone but also by kidney and liver any changes in the levels of ALP 
will not give any precise results regarding the mineralisation activity. Nonethe-
less, if the ALP is taken from the bone specific region, then the levels of ALP 
may determine the activity of bone mineralisation. In fact, lower levels of ALP 
or dysfunctionality of ALP leads to disorder recognised as hypophosphatemia 
which results in hypercalcemia causing death in children. TSP1 (Thrombos-
pondin1) and TSP2 (Thrombospondin2) are found in mesenchymal stem cells 
and chondrocytes in the process of development of cartilage in the primary 
steps of bone development. TSP2 enhances the process of mineralisation as 
well as it escalates the osteoid process during mineralisation. Both vitronectin 
and fibronectin attaches to the cells where the vitronectin helps in attachment 
of cells which are found in plasma membrane of osteoclast and works with the 
osteopontin for binding osteoclasts to the matrix of mineral. The fibronectin 
plays an important role in cell proliferation during formation of bone.
3. SIBLING also known as small integrin binding ligand N linked glycoprotein 
which includes dentin matrix acidic phosphoprotein 1 (DMP1), osteopontin, 
sialoproteins and MEPE (matrix extracellular phosphoglycoprotein). In the 
preliminary stages of osteogenesis osteopontin is secreted. The ostoponin ex-
ists near the periodontal region of teeth as well as the cement line of bone. It 
restricts the crystal growth during mineralisation, also it attaches itself to the 
osteoclast in order to enhance the binding of osteoclast to the mineral surface 
of bone in the course of bone resorption. DEMP1 has an immense inclination 
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for hydroxyl apatite and N-telopeptide region of type I collagen, also is indi-
cated by osteocytes and osteoblasts. It helps in local regulation of bone miner-
alisation. Although, it is quite an unknown fact whether DMP1 is involved in 
the differentiation process of osteoblasts to osteocytes. But in adequate DMP1 
results in hypophosphatemia rickets due to increased level of FGF23. MEPE 
also belongs to SIBLING genre which functions to locally regulate Mineralisa-
tion. It is mainly found in osteocytes and odontoblasts, where it is supremely 
demonstrated in tissues which are still under Mineralisation such as modifi-
cation of intramembrane and endochondral plaited bone of your fractured 
callus. In vivo results show that lack of MEPE gives increased bone mass as well 
as decreased in bone loss.
4. Osteocalcin (Gla bone protein): The osteocalcin is indicated in osteoblasts as 
well as osteocytes. It helps in binding o calcium and deposition of mineral. As a 
result, it is considered as an indicator of bone formation. However sometimes 
It may also behave as a precursor in regulation of osteoclasts. It has been seen 
that mice in absentia of osteocalcin suffers from grave osteoporosis. Hence, it 
can be seen why osteocalcin is considered as one of the important marker for 
bone remodelling. It has been also observed that post-menopausal osteoporosis 
that its increased level increases bone remodelling rate causing acute imbal-
ance between resorption and formation of bone.
5. Osteonectin are also known as SPARC, i.e., secreted proteins acidic rich in cys-
teine. It is present at mineral deposited location where it bonds with collagen, 
hydroxyapatite and vitronectin. It helps proliferation of freshly nucleated min-
eral crystals. Since its plays a vital part in osteoblasts growth, its non-existence 
causes osteopenia i.e. low bone density. It bandages itself to various growth 
factors such as FEF2, PDGF (platelet derived growth factor), VEGF (vascular 
endothelial growth factor) for the regulation of mineralisation.
3. Bone mineral
Bone mineral is made up of carbonate apatite which has poor crystalline struc-
ture. The apatite undergoes nucleation in the space between collagen fibrils end 
called hole zones and it spreads longitudinal over the collagen fibrils. In the begin-
ning, mineral is settled in the form of amorphous calcium phosphate followed by 
calcium carbonate in good amount. The carbonate proportion reduces during bone 
tissue maturation, also mineral crystals form disc like structure growing laterally 
while aligning themselves parallel to the fibrils of collagen. The l-axis (long axis) of 
mineral disc oriented with the longitudinal line of bone. The typical size of mineral 
crystals has less than 10 nm thickness. Gradually, the mineral disc merge with other 
crystals to form a large polycrystalline structure, which becomes indeed larger than 
the thickness of fibrils. The mineral crystals grow more in size during bone age-
ing due to changes in ion contents of mineral composition. The age of the tissue is 
directly proportional to the size of the crystals. Although, it is tough to differentiate 
amid small crystals bearing numerous defects and large crystals having less defects, 
as both shows likewise crystalline behaviour. The soluble carbonate which adheres 
to surface of crystals can also be filled in by hydroxyl and phosphates groups of 
carbonate apatite. As a result, it helps in easy resorption of mineral. During the 
incidents of acid load, bicarbonate (-HCO3) is being absorbed so as to maintain the 
pH of blood. The deficiency of -HCO3 is balanced by the presence of carbonate and 
phosphate ions in bone mineral. When there is an abnormal production of acid, the 
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bone mineral tank helps in the maintenance of acid–base balance, which also many 
times leads to loss in bone mass. There are certain cations such as Mg, Na, strontium 
in place of calcium ions and fluoride ions in place of hydroxyl ions in apatite matrix. 
Also, these kinds of substitutions can cause changes in mechanical properties of 
bone as well as in the behaviour of osteoclast and osteoblasts. Previously, for osteo-
porosis sodium fluoride used as an anabolic remedy. It was observed that sodium 
fluoride promoted pre-osteoblasts and osteoprogenitor cells hence stimulating 
uninterrupted formation of bone without the initialization of resorption. However, 
it has been seemed that carbonate apatite is less unaffected by resorption than 
fluoro-apatite. Also, replacement of fluoride ions into the mineral leads to escalated 
brittleness of bone thus causing the bone prone to fracture. The poor mechanical 
behaviour of bone is only due to the replacement of fluoride ions from bone as 
compared to the occurrence of substitutions of other ions from the bone mineral. 
The accumulation of bone mineralisation takes place in two consecutive phases. The 
first phase is the rapid nucleation of the primary mineral crystals. This phase is also 
known as primary Mineralisation. And, second phase relates to the slow prolifera-
tion and development of the primary crystals up to a size of 40 × 3 × 7.5 nm. In 
the course of primary mineralisation crystals are very quickly accumulated in the 
collagen network thus attaining 65–70% of total mineralisation within 3 weeks 
approximately. During the second step, the mineral is deposited at a steady rate but 
in a more efficient way, till the mineral attains the required bodily limit, which may 
vary from months to year [1–19].
4. Bone cells
Bone is a structurally and metabolically very complicated organ which is a 
composite of mineral, collagen material and bone cells [20]. The bone cells basically 
include osteoblasts, osteoclasts and osteocytes, which are found in mesenchymal 
stem cells known to accumulate osteiod before the mineralisation process takes off, 
thereby helping in bone formation [21, 22]. Osteoblasts are known for regulating 
mineralisation and in the formation of extracellular matrix. They are originated 
from bone and are in cuboidal form especially found at bone surface and carries 
out the function of resorption [21, 23]. The quantity and function of osteoclasts are 
dependent on many factors such as proliferation, differentiation, rate of resorption 
by already developed osteoclasts and lastly cell lineage allocation [24]. They are 
the derivative of multinucleated polarised cells which are migratory in nature with 
good source of lysozyme enzymes [25]. They consist of mitochondria of pleomor-
phic type, vacuoles and lysosomes [26]. The formation and resorption of bone is 
the joint activity of osteoclasts and osteoblasts. And the factors which are involved 
during this process are prostaglandin E2 (PGE2), transforming growth factor beta 1 
(TGF-β1), fibroblast growth factor, parathyroid hormone (PTH), osteoprotegerin 
ligand OPGL also known as RANKL (receptor activator of nuclear factor kappa 
B [(NF-ĸB) ligand]) and TRANCE i.e. TNF related activation induced cytokine. 
Resorption can also effect the biomechanical activities of bone for instance, 
formation of strong bone from a weak one [24]. Majority of bone cells are in the 
nature of osteocytes, thus comprising of 90–95% in the skeleton of an adult. The 
mature osteoblasts in the bone matrix are recognised as osteocytes. And they help 
in responding to the mechanical strain thus generating signals which can further 
coordinate the bone resorption and its formation [27]. Osteocytes that are present 
in mature bone are joined together with long extensions of cytoplasm that form 
small capillary like structure called lacunae or canalcali for the transfer of nutrients 
and wastes. Osteocytes are spread across the mineral matrix and connect to the 
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surface of bone and bone marrow via dendrites which involve osteoclast precursors 
for the stimulation of bone resorption and regulation of differentiation of mesen-
chymal stem cells [28–32]. The roles which are played by osteocytes and lacunae/
canalcali involves restriction of fatigue cracks, exchange of mineral, hormonal 
stimulation for detection of stress or strain, mending of microdamage, modelling or 
remodelling of bone under mechanical criteria, osteocytic osteolysis, regulation of 
osteoclastic cutting cone during exchange of mineral and reformed remodelling act 
after the resorption [27].
During the bone mineralisation, the crystals of mineral are accumulated in a 
systematic manner over the extracellular matrix, where the cells surrounding the 
mineral matrix prepares a pattern for mineral accumulation thus commencing the 
location for mineralisation and fixing the final dimensions of mineral crystals. 
Although, various studies have been conducted throughout the world for determin-
ing the mechanism for formation of mineral crystals in every organism, but the 
exact explanation related to this mechanism remains unclear [33–35]. In accordance 
to the conventional theories about biomineralization, NCPs were actively engaged 
in the process of matrix mineralisation. In 1994, Hunter and Goldberg postulated 
that the effects of mineralisation for BSPs were completely connected to the gluta-
mate and aspartate-rich sequences of peptides [36]. Later around 1997, Stubbs et al. 
carried out studies to consider the involvement of other groups such as sulphate, 
phosphate sialic acidic groups in the process of mineralisation [37]. According to 
earlier reports, nucleation of mineral takes place in their principal ionic solution 
which is supersaturated in nature. During nucleation in solid phase, a critical size 
of crystal is required in order to initiate the nucleation. This mechanism is known as 
stochastic solute clustering [38, 39].
At present, two important models have been considered for bone mineralisation 
process. The first model which involves mineralisation with the help of collagen 
template and the second model include the matrix vesicles for mineralisation 
purpose. It has been widely accepted that mineral formation is a systematic pro-
cedure which can never take place in the absence of matrix. Basically, the matrix 
gives an ordered pattern of deposition of mineral, thus directly participating in the 
mineralisation by behaving as a nuclear. It has been also seen that different min-
eralised tissues have different matrices [40]. Alternatively, matrix vesicles are the 
particles derived from extracellular matrix having a diameter of 100 nm, precisely 
positioned inside the bone matrix and the matrix of cartilage and peridentin. 
They provide the initial location for the calcification of all skeletal tissues. They 
are generally formed from a polarised bud which gets discharged from surface of 
the chondrocytes, osteoblasts and odontoblasts [41, 42]. The matrix vesicles are 
considered for preliminary location for mineral build-ups in bone tissue [43, 44]. In 
course of mineralisation involving cells, the formation of primary hydroxyapatite 
crystals takes place inside the vesicle membrane matrix [45].
a. Collagen-moderated mineralisation: In this type of mineralisation, the template 
for accumulation of mineral is provided by the collagen present in the bone 
tissue. And, these very collagen fibrils decide the sizes of crystals that can 
attained for the process of mineralisation. On the other hand, mineralisation 
does not take place in a deficiency of NCPs because they behave as molecules 
that generate signals all through the course of mineralisation [40, 46]. It was 
observed that BSPs role as a crystal nucleator, affected the osteocalcin recogni-
tion and remodelling of mineralised surfaces [36, 37, 47–51]. However, osteo-
pontin and osteonectin helped in regulation of crystal formation on the basis of 
size, type and growth [52, 53]. During the growth phase, the crystals nucleates 
from an amorphous phase were the intervallic pattern of 67 nm cross-striated 
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collagen fibres [54, 55] carryover the nucleation in the 40 nm long gap sparsely 
dense zone. The aforementioned process was recommended to be guided by 
heavily acidic NCPs [56–59]. The basic principal of collagen based template 
mineralisation focuses mainly on the job of collagen fibrils during bone 
Mineralisation. When the mineralising fibre were observed under cryo-trans-
mission electron microscope, it was found that polyaspartic acid which has 
soluble behaviour plays an integral part in collagen mineralisation [56, 60]. The 
calcium triphosphate ions complex is formed from the prenucleated clusters of 
acidic polypeptide [38]. These clusters are negatively charged; as a result, they 
get attracted towards the positive part on collagen [56]. Consequently, these 
ionic complex gets fused inside the collagen fibrils and then transform into 
a solid amorphous mass which further grows into an ordered apatite crystal 
complex regulated by the arrangement of collagen fibrils [40].
b. Matrix-vesicle moderated mineralisation: In this type of mechanism, the pre-
liminary phase starts off at the mineral visceral where the Ca2+ ions and the 
inorganic phosphate (Pi) are formed in vivo [41, 61, 62]. The annexins and 
phosphatidylserine are the calcium binding molecules which tag them with 
BSPs so as to invite and regulate the deposition of calcium and phosphate 
ions previous to the creation of crystals of insoluble hydroxyapatite [62, 63]. 
During, this phase the pH of the intravesicules rises above due to the activity of 
carbonic anhydrase found in mineral vesicles [64], causing the stabilisation of 
primary mineral crystals [42]. In the second phase of matrix moderated min-
eralisation, the breakdown of mineral vesicles membranes takes place where 
the already formed hydroxyapatite are exposed to extracellular fluid [61]. The 
extracellular fluid comprises of matrix vesicles with homeostatically regulated 
levels of PO4
3− and Ca2+ in order to help in proliferation of new hydroxyapatite 
crystals onto the already formed hydroxyapatite crystals. The perforations in 
the matrix vesicle membrane are carried out by proteases [65] and phospholi-
pases [66]. The metalloproteinases of matrix vesicles which have the capability 
of degenerating mineral deficient proteoglycans helps in transferring of min-
eral towards itself [67]. In the recent studies, it has been observed that collagen 
type II and X bind to the outside surfaces of matrix vesicles thus acting as a 
channel for the transfer of crystals into the extravesicular matrix [68]. Three 
promising functions of matrix vesicles have been identified during the course 
of mineralisation. The first function involves the control of ion concentration 
by the matrix vesicles inside the matrix so as to start off the mineralisation 
around the collagen fibrils. Also, it controls the compositions of ions necessary 
for the formation of intravesicular apatite crystals thus starting the process of 
mineralisation with the transfer of ions to the collagen. And lastly, when the 
mineral vesicles interact with the collagen, the deposition of mineral onto the 
surface of fibrils is carried out [40].
5. Pathological mineralisation
Mineralisation is categorised into physiological or pathological types depending 
on the type of bone tissues i.e. hard bone tissue or soft bone tissue. Physiological 
mineralisation is required for the development of skeletal tissues in order to carry 
out daily functions of a normal human life. The second category of mineralisation is 
pathological mineralisation also known as ectopic which involves the mineralisation 
of soft bone tissues such as cartilages (articular cartilage) and tissues surrounding 
cardiac vessels that causes diseases and death. Recently, it has been found that the 
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reasons and aspects which cause physiological mineralisation can be similar to that 
of pathological. Lately, it has been reported both the mineralisation are instigated 
by the matrix vesicles where the particles which resides inside the membrane are 
released from the plasma membrane of mineralisation cells. The activators and 
regulators which cause pathological mineralisation are the same activators and 
regulators which will cause pathological mineralisation. It has been also reported 
that apoptosis causes physiological mineralisation and it has been seen that if 
physiological mineralisation happens to happen take place after injury of tissue, can 
prompt pathological mineralisation around the damaged or the injured tissue [69]. 
The mineralisation process is important for imparting mechanical properties in the 
bone [70]. As a result, when not regulated properly can lead to the inadequate or 
extreme mineralisation. Therefore, bone tissue quality gets jeopardised and becom-
ing the cause for many bone related diseases. Osteomalacia is one such condition 
where the disease is caused in adults due to deficiency of bone mineral or excessive 
bone resorption. Rickets is the osteomalacia in children. As already explained, in 
a fit and mature bone, osteoclasts eliminate bone whereas osteoblasts accumulate 
osteoid and thus carrying out the mineralisation. During osteomalacia, calcification 
rate is decreased while the bone surface is being increased due to the building up of 
non-mineralised osteoid. The common symptoms of osteomalacia involves brittle 
bone, weakened muscles along with severe body ache [71–73]. Another known 
disease caused by pathological mineralisation is fibrous osteodystropy. In various 
findings, it has been seen that the flexibility and deformation of bone depends 
because of constant and extreme contact with the PTH, thus hampering with the 
bone load bearing capacity [74–78]. In osteocalcia, bone tissue is destroyed and 
resorped osteoclasts where the remodelling area, previously taken up by calci-
fied bone is then occupied by fibrous connective tissue. As the disease progresses, 
non-mineralised formed bone takes up the place of cortical bone. And also, min-
eralised osteoid in the remodelling space was previously filled up by osseous tissue 
[79]. Paget’s disease is a very commonly known disorder of bone in adults which is 
chronic in nature. This is also known as osteitis deformans [80, 81]. This is mainly 
found in middle aged men as compared to women [80, 82, 83]. In this disease, the 
resorption mechanism of bone gets speed up which results in formation of thick 
unarranged bone mineral matrix. As a result, producing weakened bone structure, 
painful fragile bone, joints arthritis inside the targeted bone. Sometimes, Paget’s 
disease transform into a preliminary cancer of bone identified as Paget’s sarcoma. 
The large multinucleated osteoclasts initiate the pathological Mineralisation of 
bones with high resorption causing Paget’s disease [84]. This hastened resorption 
results in an unorganised deposition of mineral by osteoblasts during remodelling 
[85]. Thus causing irregularities in cortical thickness, coarsening of trabecular and 
vascularization of fibrous tissues, which then produces fatigue during high stress 
condition [81, 86, 87]. Another very well-known bone disease is osteoporosis, 
where the affected bone has depleted mass with structural degradation as well as 
amplified porosity of bone tissue [88]. Usually, in osteoporosis all bones are affected 
as compared to the Paget’s disease where only a part of bone is targeted. When the 
mineral content of the bone goes below the critical value, the bone becomes more 
brittle in nature thus the load bearing capacity along with other mechanical proper-
ties of bone gets deteriorated [89]. The BMD also known as bone mineral density 
is directly proportional to the mechanical strength of bone. The patients with 
ongoing history of osteoporosis has reduced BMD, hence are more prone to fracture 
[90–93]. There are basically three main reasons behind the cause of osteoporosis. 
The first reason postulates that the commencing of the osteoporosis may be due to 
the underdevelopment of bone during the growth period of individuals. The second 
reason focuses on the bone development due to heightened resorption process. 
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And lastly, osteoporosis may happen due to the lack of new bone growth during the 
course of remodelling [94]. Earlier, it was believed that osteoporosis is an outbreak 
of ageing process but with the recent studies it has been observed that it may be 
caused because of malnutrition, alterations in biomechanical loading, production 
of excessive hormones and prolonged history of acidosis [95].
6. Mineralisation of synthetic biomaterials
For many years, biomaterials are being experimented in such a way so as to 
choose them as a replacement for damaged or diseased tissues. As the exclusive 
qualities of bone tissues are solely connected to the bone mineralisation, thereby 
interpreting and regulating the mineralisation process of artificial bone replace-
ment is very crucial [20].
6.1 Inorganic materials
Since the mineral part of the bone is inorganic in nature, many biomaterials 
such as calcium phosphates, hydroxyapatite and bioglass are being used as bone 
alternatives [96]. It was in 1969, it was observed that bioglass forms bond with the 
bone thus restricting the development of fibrous tissues surrounding the bone [97]. 
There are various other ceramic biomaterials available such as hydroxyapatite [98], 
β-tricalcium phosphate, glass–ceramic [99–101], which are after sintering have 
displayed the bone bonding ability, hence paving the way for themselves clinically 
in reconstructive and regenerative medicine fields [102].
6.2 Calcium phosphates
The first in the list of very commonly used bioceramics are the calcium phos-
phate based ceramics, broadly used in the field of dentistry and orthopaedics. They 
are mainly used for purpose of coatings onto the top surface of metal implants 
such as titanium, etc. The study of mineralisation can be performed in some fluids 
which imitates the ionic composition of blood plasma. One such kind of fluid is 
simulated body fluid suggested by Kokubo et al. in 1991. This fluid mimics the 
ionic concentrations of human blood plasma almost exactly. This fluid is used for 
the purpose of studying mineralisation behaviour of biomaterials in vitro. The 
SBF initiates the formation of apatite (bone-like) over the synthetic biomaterial 
surfaces, thus giving the idea of mineralisation of the biomaterial in vivo [103]. 
Kokubo et al. also suggested that in vivo bone reaction of an artificial biomaterial 
can be anticipated by the formation of apatite over its surface in SBF, but this theory 
now has been challenged [104]. In 2010, Bertazzo et al. suggested that calcium 
phosphates exhibited the osteoconductive nature of bone guided by bone tissues 
beside the biomaterial surface at the site of implantation orthotopically. Also, there 
are other calcium phosphate ceramics present which shows osteoinductive traits i.e. 
ability to form bone at implantation site ectopically. Although, the exact mechanism 
behind the osteoinductive nature of certain calcium phosphates depend on various 
factors such as composition, structure and conformation of the calcium phosphate 
biomaterial [105].
6.3 Bioactive glasses
In 1969, Hench observed that certain silicon-based glasses formed bond with 
the bone [106] and named it as Bioactive® glass also known as 45S5 consisting of 
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45 wt% of SiO2, 24.5 wt% of CaO, 24.5 wt% of Na2O and 6 wt% of P2O5.it can be 
synthesised by two methods which are sol-gel and melt-quench. Because of its awe-
some response towards the bone formation in vivo, it has been considered for more 
clinical applications in the arena of orthopaedics. To comprehend the behaviour of 
bioglasses in vivo, they have been submerged in SBF to analyse the physio-chemical 
route of Mineralisation onto the material surface. It has been found that a carbon-
ated apatite layer is formed which is almost like bone mineral. The mineralisation 
behaviour of calcium phosphate ceramics and bioglasses follow the same mecha-
nism for the apatite formation, thus establishing a bond (chemically) between the 
host bone and biomaterial [107].
6.4 Organic materials
Moreover, along with inorganic biomaterials there are other organic biomaterial 
in the form of biopolymers are available which also shows excellent properties to be 
considered for tissue regeneration. Such kind of polymers is PLA (polylactic acid), 
PGA (polyglycolic acid), collagen, hyaluronic acid and many more. The biopoly-
mers do not help in the formation of bone as that of bioceramics but they act as a 
supporting matrix for the treatment of damaged bone. The biopolymers are broadly 
divided into two categories I.e. Hydrated and non-hydrated polymers depending on 
the water retention ability [20].
6.5 Hydrated biopolymers
Hydrogels are considered under this label as the water is taken up by the poly-
meric network making them swollen in shape. Since they can take up water very 
quickly and can retain it, they are considered mainly for the application of cell 
culture, drug delivery and tissue engineering. On the other hand, they cannot be 
considered for bone regeneration purpose as they cannot provide any mechanical 
stability to the affected site [108, 109]. Also, the water content of hydrogels gets so 
high that it becomes almost impossible to sterilise them [110]. Furthermore, they 
fail to develop any with the surrounding tissues. The researchers around the world 
are trying to initiate mineralisation in the hydrogels by incorporating bioceramic 
particles such as calcium phosphates, hydroxyapatite or bioglass. Also, introduction 
of enzymes which catalyses the mineralisation activity into the hydrogels or inject-
ing certain artificial analogues to the matrix vesicles in order to trigger biominerli-
sation. And, lastly the polymeric hydrogels are charged with negative ions or groups 
in order to invite positively charged calcium ions and thus stimulating mineralisa-
tion in inert hydrogels [110].
6.6 Non-hydrated biopolymers
This category includes many biopolymers such as PLA, PGA, collagen, chitosan, 
etc. to be considered broadly in the field of tissue engineering. The scaffolds which 
are made up of non-hydrated polymers can be developed by various techniques such 
as 3D printing [111], porogen leaching [112], fibre meshing, microsphere sinter-
ing [111], phase separation gas foaming [113], and supercritical fluid processing 
[114]. The scaffold so developed by aforementioned processing techniques differ 
in surface properties and porosities [115]. Mineralisation of these polymers can be 
attained by various ways such as incubating in SBF, modifying surface with anionic 
groups so as to attract calcium ions over the surface of biomaterial. In non-hydrated 
polymers the assessment of mineralisation behaviour can be studied using SBF 
similar to bioceramic scaffolds. The nature of SBF taken for mineralisation activity 
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impacts the ionic composition and the configuration of mineral phase for example 
more concentrated form of SBF speeds up the bone mineralisation. The negatively 
charged proteins play integral role in controlling the deposition of mineral phase 
onto the natural bone, thus affecting the mineralisation in SBF. Hence, the surface 
of biopolymer is functionalized with negatively charged proteins or bone related 
proteins so as to trigger biominerlisation [116–120].
7. Conclusions
Bone is a very complex organ which has hierarchical organised tissue that helps 
in giving protection and support mechanically to all the organs including brain 
because of its mineralised behaviour. The mineralisation of bone is mediated by 
either collagen or matrix vesicles. Both the pathways are interconnected; but, their 
interconnectivity is still not extensively studied. By studying the mineralisation pat-
tern of bone, several bone related diseases caused due to pathological mineralisation 
or other reasons lacking in the mineralisation can be cured with the help of develop-
ment of advanced biomaterials which may showcase equivalent levels of biological 
functioning when compared to the natural bone.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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